Search research articles
Contact Us
Filters
Showing results (1151-1160 of 1,175) with videos related to
Page
of 118
Sort By:
Current Pharmaceutical Biotechnology
|
April 18, 2025
A Comprehensive 4-Layered In Silico Pharmacogenomics Analysis of the Genetic Addiction Risk Severity (GARS) Test: Strong Genetic Evidence Supporting GARS as a Novel Personalized Pre-Addiction Assessment Tool in the Opioid Crisis Era
Alireza Sharafshah, Kai-Uwe Lewandrowski, Igor Elman, et al.
Contemporary Clinical Trials
|
October 24, 2015
Lumbar Imaging With Reporting Of Epidemiology (LIRE)--Protocol for a pragmatic cluster randomized trial
Jeffrey G Jarvik, Bryan A Comstock, Kathryn T James, et al.
Current Neuropharmacology
|
January 27, 2025
In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide Ideation and Substance Use Disorder
Alireza Sharafshah, Kai-Uwe Lewandrowski, Mark S Gold, et al.
JAMA Network Open
|
September 5, 2020
The Effect of Including Benchmark Prevalence Data of Common Imaging Findings in Spine Image Reports on Health Care Utilization Among Adults Undergoing Spine Imaging: A Stepped-Wedge Randomized Clinical Trial
Jeffrey G Jarvik, Eric N Meier, Kathryn T James, et al.
Acta Scientific Neurology
|
September 2, 2025
Dopaminergic Homeostatic Therapy (DHT<sup>™</sup>) as a Putative Anti-Addiction Seeking Intervention and Early Identification of Genetic Preaddiction with Genetic Addiction Risk Severity (GARS<sup>®</sup>) Screening
Kai-Uwe Lewandrowski, Abdalla Bowirrat, Albert Pinhasov, et al.
Biorxiv : the Preprint Server for Biology
|
June 19, 2024
Ribosome-Associated Vesicles promote activity-dependent local translation
Eva Martin-Solana, Stephen D Carter, Eric K F Donahue, et al.
Gene & Protein in Disease
|
May 20, 2024
Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequences
Kenneth Blum, Abdalla Bowirrat, David Baron, et al.
British Journal of Healthcare and Medical Research
|
May 8, 2026
Reward Deficiency Syndrome (RDS): A Common Neurogenetic Trait/State of All Addictions: Is this the new DSM?
Kenneth Blum, Kai Uwe Lewandrowski, Morgan P Lorio, et al.
Current Pharmaceutical Biotechnology
|
March 14, 2026
Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety
Kenneth Blum, Alexander P L Lewandrowski, Alireza Sharafshah, et al.
Science Advances
|
March 15, 2024
Redirecting raltitrexed from cancer cell thymidylate synthase to <i>Mycobacterium tuberculosis</i> phosphopantetheinyl transferase
Amrita Singh, Samantha Ottavi, Inna Krieger, et al.
Page
of 118
Search research articles
Search
Showing results (1151-1160 of 1,175) with videos related to
Sort By:
Page
of 118
Current Pharmaceutical Biotechnology
|
April 18, 2025
A Comprehensive 4-Layered In Silico Pharmacogenomics Analysis of the Genetic Addiction Risk Severity (GARS) Test: Strong Genetic Evidence Supporting GARS as a Novel Personalized Pre-Addiction Assessment Tool in the Opioid Crisis Era
Alireza Sharafshah, Kai-Uwe Lewandrowski, Igor Elman, et al.
Contemporary Clinical Trials
|
October 24, 2015
Lumbar Imaging With Reporting Of Epidemiology (LIRE)--Protocol for a pragmatic cluster randomized trial
Jeffrey G Jarvik, Bryan A Comstock, Kathryn T James, et al.
Current Neuropharmacology
|
January 27, 2025
In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide Ideation and Substance Use Disorder
Alireza Sharafshah, Kai-Uwe Lewandrowski, Mark S Gold, et al.
JAMA Network Open
|
September 5, 2020
The Effect of Including Benchmark Prevalence Data of Common Imaging Findings in Spine Image Reports on Health Care Utilization Among Adults Undergoing Spine Imaging: A Stepped-Wedge Randomized Clinical Trial
Jeffrey G Jarvik, Eric N Meier, Kathryn T James, et al.
Acta Scientific Neurology
|
September 2, 2025
Dopaminergic Homeostatic Therapy (DHT<sup>™</sup>) as a Putative Anti-Addiction Seeking Intervention and Early Identification of Genetic Preaddiction with Genetic Addiction Risk Severity (GARS<sup>®</sup>) Screening
Kai-Uwe Lewandrowski, Abdalla Bowirrat, Albert Pinhasov, et al.
Biorxiv : the Preprint Server for Biology
|
June 19, 2024
Ribosome-Associated Vesicles promote activity-dependent local translation
Eva Martin-Solana, Stephen D Carter, Eric K F Donahue, et al.
Gene & Protein in Disease
|
May 20, 2024
Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequences
Kenneth Blum, Abdalla Bowirrat, David Baron, et al.
British Journal of Healthcare and Medical Research
|
May 8, 2026
Reward Deficiency Syndrome (RDS): A Common Neurogenetic Trait/State of All Addictions: Is this the new DSM?
Kenneth Blum, Kai Uwe Lewandrowski, Morgan P Lorio, et al.
Current Pharmaceutical Biotechnology
|
March 14, 2026
Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety
Kenneth Blum, Alexander P L Lewandrowski, Alireza Sharafshah, et al.
Science Advances
|
March 15, 2024
Redirecting raltitrexed from cancer cell thymidylate synthase to <i>Mycobacterium tuberculosis</i> phosphopantetheinyl transferase
Amrita Singh, Samantha Ottavi, Inna Krieger, et al.
Page
of 118